Weina Li
Taiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A ROR1 targeted bispecific T cell engager shows high potency in the pre-clinical model of triple negative breast cancer.
Journal: Breast cancer research : BCR
Published: December 15, 2024
MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1.
Journal: Protein and peptide letters
Published: March 05, 2024
Cancer cell-derived exosomal miR-20a-5p inhibits CD8+ T-cell function and confers anti-programmed cell death 1 therapy resistance in triple-negative breast cancer.
Journal: Cancer science
Published: July 12, 2023
(R)-9bMS Inhibited the Protein Synthesis and Autophagy of Triple Negative Breast Cancer Cells via Regulating miR-4660/mTOR Axis.
Journal: Protein and peptide letters
Published: August 24, 2022
MicroRNA-137 Inhibits Esophageal Squamous Cell Carcinoma by Downregulating DAAM1.
Journal: Protein and peptide letters
Published: March 15, 2022
Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis.
Journal: Molecular medicine reports
Published: August 16, 2020
CD63+ Cancer-Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR-22.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 02, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026